NCT03730467 (PONCTABCESEIN) is a clinical trial of Phone call to the patient in Breast Abscess, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT03730467?

NCT03730467 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT03730467?

Interventions in NCT03730467: Phone call to the patient.

What condition does NCT03730467 study?

NCT03730467 studies Breast Abscess.

Is NCT03730467 still recruiting?

NCT03730467 is currently withdrawn. Last updated 3 April 2026.

Last reviewed 2026-04-03 · How we verify

NCT03730467: PONCTABCESEIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Puncture Breast Abscess

Withdrawn Last updated 3 April 2026

What this trial tests

trial testing Phone call to the patient in Breast Abscess. Withdrawn.

Timeline

4 September 2018

Primary endpoint
4 September 2018

4 September 2018

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	4 September 2018
Primary completion	4 September 2018
Estimated completion	4 September 2018
Sites	1 location across France

Drugs / interventions tested

Phone call to the patient

Conditions studied

Breast Abscess — all drugs for Breast Abscess →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, female only, with Breast Abscess. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Several breast diseases can complicate breastfeeding : 4% of women develop a mastitis and 1% develop an abscess. The study deals with cases of breast abscess that have been treated according to a defined protocol (Parisian Perinatal Health Network), by a multidisciplinary team (center of Medical Imaging Duroc) trained in breastfeeding and ultrasound-guided punctures. The aim of the study is to define the risk factors for the onset of a breast abscess, to evaluate the indications and methods of management of abscess by ultrasound puncture, and to provide arguments motivating the continuation of breastfeeding.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03730467 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 3 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03730467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing